Cervical Lymphadenopathy in Two Young Women The Same Rare Diagnosis with Different Presentations by Canadas, Sonia et al.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2020_001516 European Journal of Case Reports in Internal Medicine © EFIM 2020
Doi: 10.12890/2020_001516 - European Journal of Case Reports in Internal Medicine - © EFIM 2020
Cervical Lymphadenopathy in Two Young Women 
The Same Rare Diagnosis with Different Presentations
Sónia Canadas1, Rita Fernandes1, Mónica Santos2, Ana Vera-Cruz3, Ana Teresa Moreira1
1Medicine Department, Internal Medicine Service, Hospital Sousa Martins, Guarda, Portugal
2 Hematology Service, Centro Hospitalar Tondela-Viseu, Viseu, Portugal
3 Medicine Department, Internal Medicine Service, Hospital Distrital de Santarém, Santarém, Portugal
Received: 23/01/2020
Accepted: 24/01/2020
Published: 10/03/2020
How to cite this article: Canadas S, Fernandes R, Santos M, Vera-Cruz A, Moreira AT. Cervical lymphadenopathy in two young women - the same rare 
diagnosis with different presentations. EJCRIM 2020;7: doi:10.12890/2020_001516.
Conflicts of Interests: The Authors declare that there are no competing interests.
Acknowledgements: We thank Joanne Lopes for the histological images, which greatly improved this publication.
This article is licensed under a Commons Attribution Non-Commercial 4.0 License
ABSTRACT
Kikuchi-Fujimoto disease (KFD) is a rare, benign and usually self-limiting disorder that more often affects young women, which is 
characterized by cervical lymphadenopathy and fever. Clinical presentation may be indistinguishable from other diseases, and its inclusion 
in the differential diagnosis of lymphoproliferative, infective and autoimmune diseases is essential. An association with systemic lupus 
erythematosus is acknowledged. We present 2 different cases of 2 young women with KFD; the first case highlights the classic diagnostic 
features of this rare entity, and the second, the findings when KFD occurs in association with systemic lupus erythematosus.
LEARNING POINTS
• Fever and cervical lymphadenopathy presenting in a young woman are the main features of KFD.
• A timely excisional lymph node biopsy is of the utmost importance in establishing a correct diagnosis and in the management of this 
condition.
• In most patients with KFD the course of the disease is benign and self-limiting; however, when associated with other conditions (mainly 
systemic lupus erythematosus) it can follow a more severe evolution.
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CASE PRESENTATION
Case 1
A 26-year-old Caucasian woman was referred to the Hematology Consultation due to cervical adenopathies of 1 month’s duration. She 
also complained of fever, night sweats, weight loss (10 kg in 3 months) and asthenia with no anorexia. Apart from a past medical history of 
breast fibroadenoma and recurrent tonsillitis (no episodes in the previous 4 months), she was otherwise healthy. On physical examination, 
she had multiple slightly tender, firm, bilateral cervical adenopathies, measuring approximately 2–3 cm; the remainder of the examination 
was unremarkable, with no hepatosplenomegaly. Investigation revealed minor leucopenia and thrombocytopenia, a slightly elevated 
erythrocyte sedimentation rate (ESR; 33 mm/h) and C-reactive protein (CRP) levels (1.15 mg/dl), normal lactate dehydrogenase (LDH), 
a normal autoimmune panel and negative serologies. Abdominal ultrasound was normal. 18F-fluorodeoxyglucose positron emission 
tomography/computed tomography (18F-FDG PET/CT) was perfomed and showed enlarged hypermetabolic supradiaphragmatic nodes with 
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a maximum standardized uptake value of 7.6, indicating high-grade lymphomatous lesion activity. The final diagnosis was established based 
on histopathological results from the excisional biopsy of a lymph node that showed partial distortion of the architecture with extensive 
paracortical necrotic areas and abundant karyorrhectic debris, with proliferation of crescentic histiocytes and plasmacytoid monocytes, 
in the absence of polymorphonuclear neutrophils. Immunohistochemical studies – CD3+, CD5+, CD4+ and CD8+, predominance of 
CD8+, some CD20+ (peripheral), CD68+ and CD163+ (multiple histiocytoid cells) – corroborated the diagnosis of histiocytic necrotizing 
lymphadenitis (Kikuchi’s disease). A diagnosis of KFD was rendered and treatment with non-steroidal anti-inflammatory drugs (NSAIDs) 
for 2 weeks provided a favourable course, with complete resolution of clinical and laboratory signs. The patient is still undergoing active 
surveillance without evidence of recurrence. 
Case 2
A 25-year-old Caucasian female nurse was referred to the Internal Medicine Consultation presenting with complaints of low fever, asthenia, 
weight loss and cervical lymphadenopathies over the previous 3 months. She also presented with a history of 12 months of arthralgias and 
joint stiffness upon waking, with major involvement of the knees, wrists, ankles and proximal and distal interphalangeal joints. As she noticed 
worsening over the previous 3 months, she was taking ibuprofen almost every morning. There was no other regular medication. There was a 
past medical history of allergic rhinitis and atopic dermatitis and a family medical history of type 1 diabetes mellitus, vitiligo and rheumatoid 
arthritis. On physical examination, there were several tender bilateral submandibular, supraclavicular and posterior cervical, right axillary 
and inguinal adenopathies, most of these being 2 cm in diameter, and she had pruritic erythematous cutaneous lesions on the anterior thoracic 
and posterior cervical areas and shoulders. Her previous laboratory tests revealed mild leucopenia, normocytic normochromic anaemia, an 
elevated ESR (68 mm/h) and CRP levels (0.82 mg/dl), low complement levels and antinuclear antibody (ANA) positivity. Additional laboratory 
investigation, bone marrow studies and an excisional biopsy of a cervical lymph node were conducted. However, the patient’s clinical status 
deteriorated and she was hospitalized. She looked unwell, with severe asthenia, pallor, but was anicteric. Laboratory assessment at that time 
showed severe haemolytic anaemia (Table 1). A thoraco-abdomino-pelvic computed tomography (CT) scan confirmed multiple adenopathies 
– axillary, mediastinal, coeliac, mesenteric and inguinal – that ranged in size from 1 to 2.5 cm and showed mild hepatomegaly and a small 
amount of fluid in the rectouterine pouch. In addition, serology tests for syphilis, human immunodeficiency virus (HIV), hepatitis B virus 
and hepatitis C virus, Epstein-Barr virus, cytomegalovirus, toxoplasmosis, borreliosis and QuantiFERON TB testing were negative. β2-
microglobulin levels were increased, serum protein electrophoresis revealed a non-monoclonal increase in the gamma region and serum 
complement levels were greatly diminished. A positive immunological work-up corroborated the diagnosis of systemic lupus erythematosus 
(SLE) (Table 2). Bone marrow studies revealed normocellular marrow with adequate trilineage haematopoiesis with no Reed-Sternberg cells.
Due to the severity of the clinical condition with decreasing haemoglobin levels, imperative  treatment with corticosteroid therapy at a high 
dose was started (methylprednisolone 1.5 mg/kg/day for 5 days), while we were waiting for the histological results. 
Table 1. The biochemical results in the deterioration phase of Patient 2
MCV: mean corpuscular volume; MCHC: mean corpuscular haemoglobin concentration; 
ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; LDH: lactate dehydrogenase.
Result Normal Range
White cell count (109/l) 3.29 5.0–10.0
Haemoglobin (g/dl) 6.9 12.0–16.0
MCV (fl) 113.8 80–100
MCHC (g/dl) 35.9 31.0–37.0
Platelet count (109/l) 168 140–400
ESR (mm/first hour) 120 2–20
CRP (mg/dl) 3.38 <0.50
LDH (U/l) 723 125–220
Haptoglobin (mg/dl) <8.00 35.0–250.0
Serum bilirubin (mg/dl) 1.56 0.20–1.20
β2-microglobulin (mg/dl) 0.54 0.11–0.24
Serum ferritin (ng/ml) 613.9 4.6–204.0
Result
ANA 1/5,120 
(homogeneous fluorescence)
Anti-dsDNA 1/320
Anti-chromatin (anti-nucleosome) 
antibodies (positive >20 U)
224 U
Anti-histone antibodies 
(positive >2.5 U)
>7.80
Anti-Rib-P (positive >10 U/ml) 11 U/ml
Serum complement C3 (mg/dl) 
(N: 90–180)
28
Serum complement C4 (mg/dl) 
(N: 10–40)
<2
Serum complement C1q (mg/dl) 
(N: 10–25)
6.34
Table 2. Immunological results for Patient 2
ANA: antinuclear antibody; anti-dsDNA: anti-double-stranded deoxyribonucleic acid 
antibodies; anti-Rib-P: anti-ribosomal P protein antibodies; N: normal values.
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Nevertheless, these results came back inconclusive and a second excisional biopsy of a cervical lymph node was performed (even though 
the patient had already initiated steroid therapy and so the results could have been difficult to interpret). Histological examination 
revealed cellular infiltrates composed of foamy histiocytes, with areas of coagulative necrosis, compatible with a diagnosis of histiocytic 
necrotizing lymphadenitis (Fig. 1), although at this point a diagnosis of SLE-associated lymphadenitis cannot be excluded. A skin biopsy was 
also performed but the results were inconclusive. The patient’s symptoms markedly improved but she developed tachycardia and a newly 
emerged grade 3/6 systolic murmur over the precordial area and left sternal border. A 2-dimensional echocardiogram revealed: normal left 
ventricle size, normal left ventricle systolic function, concentric hypertrophy involving the interventricular septum (16 mm), the presence of 
systolic anterior motion (SAM) and clinically relevant left ventricular outflow tract obstruction (LVOTO) with a maximal systolic gradient of 
50 mmHg with moderate mitral regurgitation and mild pericardial effusion. Due to the hypertrophic cardiomyopathy findings, beta-blocker 
therapy was initiated. After 6 months, the echocardiographic findings improved. In conclusion, a diagnosis of KFD associated with SLE was 
established. Overall, the patient presented a favourable clinical outcome with the given treatment – a tapering regimen of glucocorticoids, 
azathioprine and hydroxychloroquine (HCQ).
Figure 1. Photographs of histological findings 
showing cellular infiltrates composed of 
foamy histiocytes, with areas of coagulative 
necrosis. (A) H&E staining x100; (B) x400
DISCUSSION
We report 2 clinical cases with the same diagnosis but with a very different clinical course.
KFD was first described in Japan almost simultaneously by Kikuchi and by Fujimoto and colleagues in 1972[1–5]. KFD is an extremely rare 
disease[1] and although it can affect both sexes and all age groups, it occurs more often in young women (<40 years of age).
The precise aetiology remains unknown, although several types of infection have been hypothesized to act as causal agents. Some authors 
have proposed local hyperimmune stimulation after infection, influenced by individual genetic predisposition or autoimmune mechanisms, 
as a possible pathogenic feature[2, 3]. 
KFD frequently manifests as an acute or subacute illness, evolving over a period of 2 to 3 weeks[3]. Cervical lymphadenopathies (70–
100%), usually unilateral and tender, and fever (30–50%) are the most common symptoms in KFD patients[1, 4]. Less commonly, patients 
can present with weight loss, night sweats, asthenia, arthralgias, cutaneous manifestations or hepatosplenomegaly. Rarely, generalized 
lymphadenopathies can occur (5% of cases)[5].
Laboratory tests are frequently unremarkable; however, a mild leucopenia, anaemia and, more rarely, thrombocytopenia can be found, as 
well as elevated inflammatory markers (CRP and ESR)[4].
Therefore, its inclusion in the differential diagnosis of infectious, lymphoproliferative, neoplastic and autoimmune diseases is imperative, the 
most common of these being tuberculous lymphadenitis, malignant haematologic diseases (non-Hodgkin lymphoma and Hodgkin disease) 
and SLE[5]. An initial misdiagnosis as malignant lymphoma is accomplished in 30% of cases[4].
The association of KFD with other pathologies has been reported, mostly autoimmune, and more commonly with SLE. The clinical, laboratory 
and histopathological features of these 2 diseases commonly overlap, making differentiation impossible in some cases. Patients with KFD 
should have long-term follow-up due to their increased risk of SLE[2, 5].
A definitive diagnosis of KFD is made by lymph node excisional biopsy. The histological findings consist of histiocytic infiltrate, areas of focal 
necrosis, karyorrhoexis, with a typical absence of neutrophils and eosinophils [3, 5]. Three evolving histologic stages are identified in KFD: 
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the proliferative, with lymphoid hyperplasia, variable histiocytic infiltrate and karyorrhexis; the necrotizing, when extensive paracortical 
or interfollicular necrosis is recognized and the xanthomatous, if there is a predominance of foamy histiocytes[3]. Immunohistochemical 
analysis constitutes an additional aid to diagnosis.
In most patients with KFD, the clinical course is benign and self-limiting. Symptomatic patients can benefit from NSAIDs for a short period 
of time or, in more severe cases, from corticosteroids, HCQ or intravenous immunoglobulin[3, 4].
Our first clinical report highlights the most common features of a KFD patient: a polyadenopathic condition presenting in a young woman, 
adenopathies mainly localized to the cervical area, with a maximum diameter of 4 cm and tender, with constitutional symptoms. The 
laboratory findings were also consistent with what is reported in the literature. In most cases, rarely seen KFD is not the most likely diagnosis, 
but an accurate diagnosis is imperative, as this can prevent unwarranted and deleterious treatments; for example, if a misdiagnosis of a 
lymphoproliferative disease were to be made. A timely excisional lymph node biopsy was of the utmost importance in establishing a correct 
diagnosis and in the management of this condition.
In our second case, a diagnosis of KFD associated with SLE was established; thus, the patient did not have a straightforward clinical 
presentation. The Systemic Lupus International Collaborating Clinics (SLICC) criteria proposed in 2012 warranted the SLE diagnosis at 
that time as 4 clinical criteria (synovitis, serositis presenting as pericardial effusion, haemolytic anaemia and leucopenia) and 4 immunologic 
criteria (ANA+, anti-dsDNA+, antiphospholipid Ab and low complement) were present. The diagnosis remains using the new 2019 SLE 
criteria. Due to the evidence of haemolysis leading to the clinical deterioration of our patient, a more agressive pharmacological approach 
was imperative.
The second excisional biopsy of a cervical lymph node rendered the diagnosis. This condition is often undiagnosed or misdiagnosed as 
sometimes the histological characteristics of KFD are indistinguishable from those found with other entities, especially in the early stages 
of the disease[3]. Our first biopsy was inconclusive for the reasons outlined; however, we still had the opportunity to make an accurate 
diagnosis, as provided by the second biopsy, which produced findings compatible with the xanthomatous phase of KFD (temporal delay, 
after corticosteroid therapy).
We also emphasize the hypertrophic cardiomyopathy findings in this young patient without a familial history of heart disease or sudden 
cardiac death. Jiang et al. reported a case of a 25-year-old woman with SLE with myocardial hypertrophy that was assumed to be related to 
high-dose prednisolone use[6]. Perhaps this could be the explanation for our patient’s unexpected clinical finding.
In conclusion, with this report we would like to increase medical awareness of this under-recognized entity, as it is a crucial inclusion in the 
differential diagnosis in cases of lymphadenopathy and fever.
